Mirvetuximab soravtansine (Elahare)
Ovarian Targeted Therapies and ADCs
•
7m 41s
Learn about Elahere (mirvetuximab soravtansine), an antibody-drug conjugate designed for adults with gynecologic cancers that are folate receptor alpha-positive and no longer responding to platinum-based chemotherapy.
Up Next in Ovarian Targeted Therapies and ADCs
-
Pembrolizumab
This video offers guidance on Pembrolizumab (Keytruda), helping you understand how this immunotherapy harnesses your immune system to fight cancer. We walk you through what to expect during infusions and provide practical tips for managing potential immune-related side effects, ensuring you feel ...
-
Bevacizumab
This video offers guidance on Bevacizumab (Avastin), helping you understand how this targeted therapy works to inhibit blood vessel growth, effectively starving tumors. We walk you through what to expect during infusions and provide practical tips for managing potential side effects—such as high ...
-
Fam-Trastuzumab-Deruxtecan (Enhertu)
